Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (SNY)
$48.46▲ +0.06%
Close Nov 12, 2026 · split-adjusted
Nov 12, 2026$48.46▼ 6.66% in range
Nov 12, 2025Low $39.12 · High $52.34Nov 12, 2026
What changed · written from our data
As of Nov 12, 2026
Sanofi American Depositary Shares (Each representing one-half of one ordinary share) closed at $48.46 on Nov 12, up 0.06%, 7.4% below its 52-week closing high. Volume of 2.4M shares was 0.49× its 20-day average (below normal).
Split-adjusted performance: +21.9% over one month, +13.1% over six months, -6.2% over one year.
Short interest was 12.3M shares at the Oct 30 settlement, up 5.9% from the prior report (2.9 days to cover).
What does Sanofi American Depositary Shares (Each representing one-half of one ordinary share) do?
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales.
What is SNY's market cap?
$116.12B, based on the Nov 12 close of $48.46.
Does Sanofi American Depositary Shares (Each representing one-half of one ordinary share) pay a dividend?
Yes. The latest regular dividend was $2.419 per share (ex-date May 4), an annualised yield of 4.99%.
About Sanofi
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
